96 results on '"Takei, Mineo"'
Search Results
2. The Asia‐Pacific AMS800 artificial urinary sphincter consensus statement
3. Outcomes of artificial urinary sphincter implantation in patients with diabetes mellitus: A subgroup analysis
4. Low quality of life in men with chronic prostatitis-like symptoms
5. Clinical Guidelines for Female Lower Urinary Tract Symptoms (second edition)
6. Efficacy and safety of intravesical instillation of KRP‐116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double‐blind, placebo‐controlled, clinical study
7. Efficacy and safety of the noradrenaline reuptake inhibitor, TAS‐303, in women with stress urinary incontinence: Results of a double‐blind, randomized, placebo‐controlled, early phase II trial
8. Symptoms and noninvasive test parameters that clinically differentiate detrusor underactivity from bladder outlet obstruction without a pressure‐flow‐based diagnosis in men with lower urinary tract symptoms
9. A Prediction Model of Detrusor Underactivity Based on Symptoms and Noninvasive Test Parameters in Men with Lower Urinary Tract Symptoms: An Analysis of a Large Group of Patients undergoing Pressure-Flow Studies
10. Z-505, an Oral Ghrelin Receptor Agonist, Attenuates Anorexia After Total Gastrectomy in Rats
11. The development of the ICIQ‐UAB: A patient reported outcome measure for underactive bladder
12. Surgical and Patient Reported Outcomes of Artificial Urinary Sphincter Implantation: A Multicenter, Prospective, Observational Study
13. Z-505 hydrochloride ameliorates chemotherapy-induced anorexia in rodents via activation of the ghrelin receptor, GHSR1a
14. Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice
15. PD26-11 SYMPTOMS AND NONINVASIVE PARAMETERS THAT PREDICT DETRUSOR UNDERACTIVITY IN MEN WITH LOWER URINARY TRACT SYMPTOMS: AN ANALYSIS USING A LARGE GROUP OF PATIENTS UNDERGOING PRESSURE FLOW STUDY
16. Z-100, extracted from Mycobacterium tuberculosis strain Aoyama B, promotes TNF-α production via nucleotide-binding oligomerization domain containing 2 (Nod2)-dependent NF-κB activation in RAW264.7 cells
17. Pharmacological and clinical profile of acotiamide hydrochloride hydrate (Acofide® Tablets 100 mg), a novel therapeutic agent for functional dyspepsia (FD)
18. Z-100, an Immunomodulatory Extract of Mycobacterium tuberculosis Strain Aoyama B, Prevents Spontaneous Lymphatic Metastasis of B16-BL6 Melanoma
19. Twelve Months Follow-up of Injection of OnabotulinumtoxinA into Vesical Submucosa for Refractory Non-neurogenic Overactive Bladder
20. The Development of Polaprezinc Research
21. Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach
22. CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells
23. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats
24. Concentration Dependence of 5-Aminosalicylic Acid Pharmacological Actions in Intestinal Mucosa after Oral Administration of a pH-Dependent Formulation
25. Acotiamide (Z-338), a Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, Restores Delayed Gastric Emptying Induced by Restraint Stress via the Vagal Afferent Pathway in Rats
26. Acotiamide (Z-338), a Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, Enhances Gastric Motility Without Prolonging QT Interval in Dogs and Rats
27. 948 CHARACTERISTICS AND TREATMENT OUTCOMES OF 458 PATIENTS WITH INTERSTITIAL CYSTITIS IN JAPAN
28. 1956 BLADDER CAPACITY AND ITS ASSOCIATION WITH THE PROFILES OF DETRUSOR OVERACTIVITY AND THE DEGREE OF SYMPTOMS RELATED TO OVERACTIVE BLADDER IN MEN WITH BENIGN PROSTATIC ENLARGEMENT
29. Voiding dynamics in women with stress urinary incontinence and high-stage cystocele
30. Acotiamide Hydrochloride (Z-338), a New Selective Acetylcholinesterase Inhibitor, Enhances Gastric Motility without Prolonging QT Interval in Dogs: Comparison with Cisapride, Itopride, and Mosapride
31. Surgical treatment of female stress urinary incontinence with a transobturator tape (Monarc): Short-term results of a prospective multicenter study
32. ChemInform Abstract: Dual-Acting Agents with α1-Adrenoceptor Antagonistic and Steroid 5α-Reductase Inhibitory Activities. Synthesis and Evaluation of Arylpiperazine Derivatives.
33. 1040 THE PREDICTORS OF SUCCESSFUL HYDRODISTENSION THERAPY IN 399 PATIENTS WITH INTERSTITIAL CYSTITIS IN JAPAN
34. Z-360, a Novel Cholecystokinin-2/Gastrin Receptor Antagonist, Inhibits Gemcitabine-Induced Expression of the Vascular Endothelial Growth Factor Gene in Human Pancreatic Cancer Cells
35. Pharmacological Evaluation of Analgesic Effects of the Cholecystokinin2 Receptor Antagonist Z-360 in Mouse Models of Formalin- and Cancer-Induced Pain
36. Z-360, a Novel Therapeutic Agent for Pancreatic Cancer, Prevents Up-Regulation of Ephrin B1 Gene Expression and Phosphorylation of NR2B via Suppression of Interleukin-1β Production in a Cancer-Induced Pain Model in Mice
37. Burden of male stress urinary incontinence: A survey among urologists in Japan
38. Polaprezinc, a zinc compound, is distributed to the lingual epithelium and increases its zinc concentration in zinc-deficient rats
39. Changes in prostate volume in Japanese patients with benign prostatic hyperplasia: Association with other urological measures and risk of surgical intervention
40. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity
41. Japanese guideline for diagnosis and treatment of interstitial cystitis
42. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction
43. Current use of the artificial urinary sphincter and its long-term durability: A nationwide survey in Japan
44. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate
45. Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro
46. Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: Analysis of 282 Japanese patients
47. Haploinsufficiency of 8p22 may influence cancer-specific survival in prostate cancer
48. Defining overactive bladder as hypersensitivity
49. CONTINUOUS BLADDER IRRIGATION FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE (TURP)
50. Predictives regarding outcome after transurethral resection for prostatic adenoma associated with detrusor underactivity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.